Abattis Bioceuticals Corp. Share Price Other OTC
Equities
ATTBF
CA00258G1037
Healthcare Facilities & Services
Sales 2018 | 8.37K 6.12K 480K | Sales 2019 | 357K 261K 20.48M | Capitalization | 8.62M 6.3M 495M |
---|---|---|---|---|---|
Net income 2018 | -78M -57.05M -4.48B | Net income 2019 | -3M -2.19M -172M | EV / Sales 2018 | 5,778 x |
Net cash position 2018 | 9.1M 6.65M 522M | Net cash position 2019 | 2.25M 1.65M 129M | EV / Sales 2019 | 17.8 x |
P/E ratio 2018 |
-0.57
x | P/E ratio 2019 |
-2.8
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99.64% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 31/03/19 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 31/10/18 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 18/10/18 |
Patrick Mitchell
COO | Chief Operating Officer | - | 31/10/18 |
Director of Finance/CFO | - | 31/03/19 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 339M | |
+23.87% | 244M | |
+8.25% | 223M | |
+40.70% | 183M | |
+150.92% | 149M | |
+33.76% | 121M | |
-28.57% | 121M | |
-44.42% | 114M | |
-7.69% | 80.53M |